Pfizer CEO had dinner with RFK Jr.
2don MSN
Pfizer shares were rising early Tuesday after the company reported fourth-quarter earnings and revenue that came in ahead of ...
Dr. Albert Bourla is also troubled by this ... “It’s a great, great honor, which I accept on behalf of everyone at Pfizer,” said Bourla. In its announcement, the Foundation highlighted ...
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite ...
Pfizer’s chief executive said he was “disappointed” with Robert F Kennedy Jr’s refusal to disavow the debunked link between vaccines and autism, even as he expressed confidence that the Trump ...
In an interview on CNBC’s Mad Money, Dr. Albert Bourla said Pfizer (PFE) is focusing on business development to create shareholder value. “We ...
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
(JTA) — Albert Bourla, the chief executive officer of Pfizer, was named the winner of the 2022 Genesis Prize, the award sometimes called the “Jewish Nobel,” and pledged his winnings to ...
Bourla outlined 2025 priorities, which include improving R&D productivity, achieving margin expansion, and maintaining commercial excellence. He highlighted expectations for nine Phase 3 readouts, 13 ...
With just one asset in weight loss moving through the clinic, Pfizer targets the space for potential dealmaking, as well as ...
Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to ...
Q4 2024 Earnings Conference Call February 4, 2025 10:30 AM ETCompany ParticipantsFrancesca DeMartino - Senior Vice President, ...
The CEO said last month that the drugmaker had cut costs, revamped its sales operation, and made other big fixes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback